HUMAN GENOME SCIENCES INC Proceeds from Common Stock Issued
HUMAN GENOME SCIENCES INC reported Proceeds from Common Stock Issued of $7.77 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for the quarter ending 2012-06-30 was $6.39M, a 28.18% decline year-over-year.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for the quarter ending 2012-03-31 was $1.38M, a 73.55% decline year-over-year.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for the quarter ending 2011-12-31 was $467.00K, a 83.20% decline year-over-year.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for the quarter ending 2011-09-30 was $3.81M, a 25.97% decline year-over-year.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for fiscal 2011 was $18.38M, a 53.19% decline from fiscal 2010.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for fiscal 2010 was $39.27M, a 95.44% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC proceeds from issuance of common stock for fiscal 2009 was $861.57M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2012-06-30 | $6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $7.77M 10-Q · filed 2012-07-26 | $8.23M derived: sum of 3 quarters · filed 2012-07-26 | $12.04M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $1.38M 10-Q · filed 2012-04-26 | $1.85M derived: sum of 2 quarters · filed 2012-04-26 | $5.65M derived: sum of 3 quarters · filed 2012-04-26 | $14.55M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $4.27M derived: sum of 2 quarters · filed 2012-02-28 | $13.17M derived: sum of 3 quarters · filed 2012-07-26 | $18.38M 10-K · filed 2012-02-28 |
| 2011-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $12.70M derived: sum of 2 quarters · filed 2012-07-26 | $17.91M 10-Q · filed 2011-10-28 | $20.69M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $8.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $14.11M 10-Q · filed 2012-07-26 | $16.89M derived: sum of 3 quarters · filed 2012-07-26 | $22.03M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $5.21M 10-Q · filed 2012-04-26 | $7.99M derived: sum of 2 quarters · filed 2012-04-26 | $13.13M derived: sum of 3 quarters · filed 2012-04-26 | $22.18M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $7.92M derived: sum of 2 quarters · filed 2012-02-28 | $16.97M derived: sum of 3 quarters · filed 2012-02-28 | $39.27M 10-K · filed 2012-02-28 |
| 2010-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $14.19M derived: sum of 2 quarters · filed 2011-10-28 | $36.49M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $9.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $31.35M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $22.30M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $861.57M 10-K · filed 2012-02-28 |